All abstracts will be peer-reviewed by the ASCO Plenary Series Review Committee and evaluated on the following criteria:

• Strength of Science: Does the research address an important and novel question?
• Research Design: Are the eligibility criteria, study endpoints, and planned analysis well defined in this abstract?
• Relevance: Are the results practice-changing? Will they have a clinical impact and be of broad interest to the ASCO community?

Abstracts of superior quality will be selected for oral presentation and for publication in an online supplement to the Journal of Clinical Oncology. The oral presentation will be given by the first author on the corresponding ASCO Presentation Date. Each abstract presentation will be accompanied by a discussant presentation then followed by a live Question and Answer. For more detailed information, please visit the full Program.

First authors will be invited to participate in a subsequent ASCO Annual Meeting session (exact presentation format to be determined). First authors will also be encouraged to submit their full manuscript for rapid review with the JCO.